PROTEMIX

Mark For: PROTEMIX® trademark registration is intended to cover the categories of pharmaceutical preparations for use in the treatment of diabetes mellitus, heart disease, kidney disease, liver disease, and fibril-medicated disease. [all]

Status

2022-08-01 UTC
⟳ Refresh

DEAD REGISTRATION Cancelled Invalidated

Research	OneLook Acronym Finder
Serial Number	76377008
Registration Number	2909469
Mark Literal Elements	PROTEMIX
Mark Drawing Type	1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S)
Mark Type	TRADEMARK. SERVICE MARK
Standard Character Claim	No
Register	PRINCIPAL
Current Location	PUBLICATION AND ISSUE SECTION 2004-12-14
Basis	44(e)
Class Status	SECTION 8 - CANCEL
Primary US Classes	006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	No
Intent To Use	No
Filed ITU	Yes
44D Filed	No
44E Current	Yes
66A Current	No
Current Basis	No
No Basis	No
Cancellation Code	2
Domestic Representative	Buchanan Ingersol, P.C.
Attorney Name	Bradford J. Duft
Attorney Docket Number	441842400100
Law Office Assigned	L50
Employee Name	MCMORROW, RONALD G

Timeline

(CANCELLED)
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations for use in the treatment of diabetes mellitus, heart disease, kidney disease, liver disease, and fibril-medicated disease(CANCELLED)
IC 042. US 100 101. G & S: Laboratory research in the field of proteomics, biochemistry, molecular biology, molecular biology, cell biology, and physiology; laboratory services in the nature of testing for new product identification and developments; quality control and testing of the development of pharmaceuticals and pharmaceutical candidates; scientific research; developing assays for the diagnosis of disease; developing chemical markers for disease states; determining targets for drugs; determining protein and peptides sequences; and development of proteomic and genomic research methodologies(CANCELLED)
IC 044. US 100 101. G & S: Medical services